|
Variables
|
SR group (n = 36)
|
AF group (n = 28)
|
χ2/t
|
P
|
|---|
|
Demographics
|
|
Age (year)
|
67.8 ± 8.8
|
66.5 ± 8.1
|
0.605
|
0.547
|
|
Gender (percent male)
|
20 (55.6%)
|
16 (57.1%)
|
0.016
|
0.899
|
|
BMI (kg/m2)
|
23.8 ± 2.9
|
25.6 ± 3.6
|
1.652
|
0.104
|
|
Smoking
|
10 (27.8%)
|
8 (28.6%)
|
0.005
|
0.944
|
|
NYHA functional class
| | |
2.709
|
0.439
|
|
I
|
5 (13.9%)
|
3 (10.7%)
| | |
|
II
|
12 (33.3%)
|
12 (42.9%)
| | |
|
III
|
16 (44.4%)
|
8 (28.6%)
| | |
|
IV
|
3 (8.3%)
|
5 (17.9%)
| | |
|
Echocardiography
|
|
LVEF (%)
|
58.8 ± 4.4
|
59.3 ± 5.0
|
0.391
|
0.697
|
|
LAD (mm)
|
37.9 ± 5.8
|
43.8 ± 3.9
|
4.547
|
< 0.001
|
|
Comorbidities
|
|
Hypertension
|
10 (27.8%)
|
6 (21.4%)
|
0.339
|
0.561
|
|
T2DM
|
12 (33.3%)
|
8 (28.6%)
|
0.166
|
0.683
|
|
Stroke
|
2 (5.6%)
|
4 (14.3%)
|
1.413
|
0.235
|
|
COPD
|
4 (11.1%)
|
4 (14.3%)
|
0.145
|
0.703
|
|
Serum YKL-40 (μg/l)
|
87.0 ± 36.6
|
101.5 ± 41.5
|
1.475
|
0.145
|
- BMI body mass index, LVEF left ventricular ejection fraction, LAD left atrial diameter, T2DM type 2 diabetes mellitus, COPD chronic obstructive pulmonary disease, NYHA New York Heart Association
